American Journal of Cardiology
Volume 99, Issue 7 , Pages 879-884 , 1 April 2007

Inflammatory Markers, Angiographic Severity of Coronary Artery Disease, and Patient Outcome

  • Rishi Sukhija, MD

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Ibrahim Fahdi, MD

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Luis Garza, MD

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Louis Fink, MD

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • ,
  • Margaret Scott, MD

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Wady Aude, MD

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Rebecca Pacheco, RN

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Zoran Bursac, PhD, MPH

      Affiliations

    • College of Public Health, Little Rock, Arkansas.
    • ,
  • April Grant, MPH

      Affiliations

    • College of Public Health, Little Rock, Arkansas.
    • ,
  • Jawahar L. Mehta, MD, PhD

      Affiliations

    • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
    • University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • Corresponding Author InformationCorresponding author: Tel: 501-296-1401; fax: 501-686-6180.

Received 18 October 2006 ,Revised 8 November 2006 ,Accepted 8 November 2006.

References 

  1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979(erratum 1997;337:356)
  2. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy (Thrombolysis In Myocardial Infarction). J Am Coll Cardiol. 1998;31:1460–1465
  3. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 2002;105:1412–1415
  4. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462–466
  5. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149–2153
  6. Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2005;165:2063–2068
  7. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? (The verdict is still out). Circulation. 2006;113:2128–2134
  8. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–1397
  9. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351:2599–2610
  10. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the Atherosclerosis Risk In Communities study. Arch Intern Med. 2006;166:1368–1373
  11. Paul SD, Eagle KA, Kuntz KM, Young JR, Hertzer NR. Concordance of preoperative clinical risk with angiographic severity of coronary artery disease in patients undergoing vascular surgery. Circulation. 1996;94:1561–1566
  12. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease (Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association). Circulation. 1975;51(suppl):5–40
  13. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  14. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non–HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326–333
  15. Wilson PW, Nam BH, Pencina M, D’Agostino RB, Benjamin EJ, O’Donnell CJ. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med. 2005;165:2473–2478
  16. Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, et al Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation. 2006;114:201–208
  17. Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J. 2005;26:241–249
  18. Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med. 2006;145:35–42
  19. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000;148:209–214
  20. Mehta JL, Li DY. Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?. Cardiovasc Res. 1999;43:291–299
  21. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003;108:161–165
  22. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation. 2006;113:38–43
  23. Redberg RF, Rifai N, Gee L, Ridker PM. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol. 2000;36:39–43
  24. Hunt ME, O’Malley PG, Vernalis MN, Feuerstein IM, Taylor JA. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J. 2001;141:206–210
  25. Kullo IJ, McConnell JP, Bailey KR, Kardia SL, Bielak LF, Peyser PA, et al. Relation of C-reactive protein and fibrinogen to coronary artery calcium in subjects with systemic hypertension. Am J Cardiol. 2003;92:56–58
  26. Reilly MP, Wolfe ML, Localio AR, Rader DJ. Study of Inherited Risk of Coronary Atherosclerosis (C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA)). Arterioscler Thromb Vasc Biol. 2003;23:1851–1856
  27. Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation. 2002;106:1189–1191
  28. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL Intermountain Heart Collaboration Study Group. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol. 2002;39:632–637
  29. Ikonomidis I, Andreotti F, Economou E, Stefenadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999;100:793–798
  30. Rifai N, Joubran R, Yu H, Asmi M, Jouma M. Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem. 1999;45:1967–1973

 This study was supported by Grant M01 RR14288 from the University of Arkansas for Medical Sciences General Clinical Research Center, Little Rock, Arkansas.

PII: S0002-9149(06)02484-2

doi: 10.1016/j.amjcard.2006.11.032

American Journal of Cardiology
Volume 99, Issue 7 , Pages 879-884 , 1 April 2007

Article Tools

* Image Usage & Resolution